C4 Therapeutics to Participate in Upcoming September Investor Conferences
WATERTOWN, Mass., Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- C4 Therapeutics, Inc. ( C4T ) ( Nasdaq: CCCC ) , a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September ...
| Ticker |
Sentiment |
Impact |
|
WFC
|
Neutral
|
17 %
|
|
CCCC
|
Somewhat Bullish
|
60 %
|
